Search

everythinglearnresearchcommunity

for

Search:↓

MNC-QQ cell therapy improved hair growth and quality of life in men with androgenic alopecia without adverse effects.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

Vitiligo causes white skin patches and is linked to autoimmune issues.

Horizontal scalp biopsy sections are better for diagnosing alopecia areata, showing fewer hair follicles and more miniaturized hairs.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Platelet-rich plasma doesn't prevent hair loss from chemotherapy, and mononuclear cells only help against hair loss from one specific chemotherapy drug.

Alopecia areata causes patchy hair loss and involves immune system disruptions.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

scMC effectively separates biological signals from technical noise in single-cell genomics data.

Shift work disrupts the body's natural clock, leading to health problems.

Alopecia areata can be triggered by specific immune cells without genetic or environmental factors.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

Apremilast may help treat hair loss in alopecia areata.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Stem cell therapy may help treat tough hair loss cases.

A new mouse model helps understand and find treatments for alopecia areata.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

Immortalized hair follicle cells could be useful for regenerative medicine and treating inflammation and oxidative stress.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

Using growth factors and microneedling shows promise for hair regrowth in Alopecia Areata, but more research is needed.

The study identified key immune cell differences between mild and severe alopecia areata.

Highly active but fewer CD14+CD16- monocytes are found in Alopecia Areata patients, regardless of severity.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.